These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29245084)

  • 1. Application of analytical quality by design principles for the determination of alkyl p-toluenesulfonates impurities in Aprepitant by HPLC. Validation using total-error concept.
    Zacharis CK; Vastardi E
    J Pharm Biomed Anal; 2018 Feb; 150():152-161. PubMed ID: 29245084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHPLC-fluorescence method for the determination of trace levels of hydrazine in allopurinol and its formulations: Validation using total-error concept.
    Christofi M; Markopoulou CK; Tzanavaras PD; Zacharis CK
    J Pharm Biomed Anal; 2020 Aug; 187():113354. PubMed ID: 32416339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by Design approach in the development of hydrophilic interaction liquid chromatographic method for the analysis of iohexol and its impurities.
    Jovanović M; Rakić T; Tumpa A; Jančić Stojanović B
    J Pharm Biomed Anal; 2015 Jun; 110():42-8. PubMed ID: 25796982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance.
    Karmarkar S; Yang X; Garber R; Szajkovics A; Koberda M
    J Pharm Biomed Anal; 2014 Nov; 100():167-174. PubMed ID: 25168215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical quality-by-design optimization of UHPLC method for the analysis of octreotide release from a peptide-based hydrogel in-vitro.
    Tzanavaras PD; Chatzitaki AT; Karavasili C; Sarigiannis Y; Fatouros DG; Zacharis CK
    J Pharm Biomed Anal; 2022 May; 214():114699. PubMed ID: 35303647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of liquid chromatographic method for the analysis of dabigatran etexilate mesilate and its ten impurities supported by quality-by-design methodology.
    Pantović J; Malenović A; Vemić A; Kostić N; Medenica M
    J Pharm Biomed Anal; 2015; 111():7-13. PubMed ID: 25828507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a LC method for the enantiomeric purity determination of S-ropivacaine in a pharmaceutical formulation using a recently commercialized cellulose-based chiral stationary phase and polar non-aqueous mobile phase.
    Dossou KS; Chiap P; Servais AC; Fillet M; Crommen J
    J Pharm Biomed Anal; 2011 Mar; 54(4):687-93. PubMed ID: 21111554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexibility and applicability of β-expectation tolerance interval approach to assess the fitness of purpose of pharmaceutical analytical methods.
    Bouabidi A; Talbi M; Bourichi H; Bouklouze A; El Karbane M; Boulanger B; Brik Y; Hubert P; Rozet E
    Drug Test Anal; 2012 Dec; 4(12):1014-27. PubMed ID: 22615163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
    Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
    J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
    Kasawar GB; Farooqui M
    J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy.
    Radić I; Runje M; Babić S
    J Pharm Biomed Anal; 2021 Jul; 201():114091. PubMed ID: 33964725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical quality by design development of an ecologically acceptable enantioselective HPLC method for timolol maleate enantiomeric purity testing on ovomucoid chiral stationary phase.
    Mitrović M; Protić A; Malenović A; Otašević B; Zečević M
    J Pharm Biomed Anal; 2020 Feb; 180():113034. PubMed ID: 31838281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination and confirmation of isopropyl p-toluenesulfonate in cosmetics by HPLC-diode array detector method and GC-MS.
    Tay BY; Yung SC; Teoh TY
    Int J Cosmet Sci; 2016 Dec; 38(6):627-633. PubMed ID: 27169828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs.
    Bianchini RM; Castellano PM; Kaufman TS
    Anal Chim Acta; 2009 Nov; 654(2):141-7. PubMed ID: 19854345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability kinetics of fusidic acid: Development and validation of stability indicating analytical method by employing Analytical Quality by Design approach in medicinal product(s).
    Sharma G; Thakur K; Raza K; Katare OP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():113-124. PubMed ID: 31082718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.